Christopher Alan Brown, MD, PhD
Neurology
Accepting new patients
Sees patients age 18 and up
Penn Memory Center
Penn Medicine Provider

About me

  • Instructor A of Neurology

Education and training

  • Medical School: University of Kentucky College of Medicine
  • Residency: Hospital of the University of Pennsylvania

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Brown is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Sreepada LP, Brown CA, Das SR, Yushkevich PA, Wolk DA, McMillan CT Biological age acceleration in Alzheimer's disease modulates relative cortical to medial temporal lobe neurodegeneration , Neurobiol Aging, 153: 2025,21-29


Cousins KAQ, Korecka M, Wan Y, Vulaj A, Brown C, Tropea TF, Lee EB, Tosun D, Landau SM, Okonkwo OC, Mindt MR, Weiner MW, Irwin DJ, Wolk DA, Shaw LM Comparison of plasma p-tau217/Aβ42, p-tau217, and Aβ42/Aβ40 biomarkers by race to detect Alzheimer's disease , Alzheimers Dement, 21(8): 2025,e70469


Brown CA, Das SR, Cousins KAQ, Tropea TF, Plotkin AC, Detre JA, Yushkevich PA, McMillan CT, Lee EB, Shaw LM, Nasrallah IM Tau burden is best captured by magnitude and extent: Tau-MaX as a measure of global tau , Alzheimers Dement, 21(7): 2025,e70346


Hrybouski S, Das SR, Xie L, Brown CA, Flamporis M, Lane J, Nasrallah IM, Detre JA, Yushkevich PA, Wolk DA BOLD amplitude correlates of preclinical Alzheimer's disease , Neurobiol Aging, 150: 2025,157-171


Xie L, Das SR, Li Y, Wisse LEM, McGrew E, Lyu X, DiCalogero M, Shah U, Ilesanmi A, Denning AE, Brown CA, Cohen J, Sreepada L, Dong M, Sadeghpour N, Khandelwal P, Ittyerah R, Ravikumar S, Sadaghiani S, Hrybouski S, de Flores R, Gibson E, Yushkevich PA, Wolk DA A multi-cohort study of longitudinal and cross-sectional Alzheimer's disease biomarkers in cognitively unimpaired older adults , Alzheimer's Disease Neuroimaging Initiative, 21(2): 2025,e14492


Taghvaei M, Dolui S, Sadaghiani S, Shakibajahromi B, Brown C, Khandelwal P, Xie SX, Das S, Yushkevich PA, Wolk DA, Detre JA Regional cerebral blood flow reflects both neurodegeneration and microvascular integrity across the Alzheimer's continuum , Alzheimers Dement, 21(2): 2025,e14382


Shakibajahromi B, Dolui S, Brown CA, Taghvaei M, Khandelwal P, Wu Q, Sadaghiani S, Yushkevich PA, Wolk DA, Detre JA MRI Correlates of Executive Function in Cognitively Normal Older Subjects , Alzheimers Dement: 2025


Sreepada LP, Brown CA, Das SR, Yushkevich PA, Wolk DA, McMillan CT Biological aging is associated with atypical neurodegenerative patterns in Alzheimer’s disease , Alzheimers Dement: 2025


Cousins KAQ, Korecka M, Yang W, Vulaj A, Brown CA, Tropea TF, Chen-Plotkin A, Lee EB, Irwin DJ, Wolk DA, Shaw LM Comparison of p-tau217 and Aβ42/Aβ40 biomarkers by race to detect Alzheimer’s disease , Alzheimers Dement: 2025


Brown CA, Das SR, Cousins KAQ, Tropea TF, Chen-Plotkin A, Lee EB, Nasrallah IM, Detre JA, Yushkevich PA, Shaw LM, Wolk DA Tau Magnitude and eXtent-Tau-MaX: Capturing Tau spread and local accumulation provides a robust metric of tau burden , Alzheimers Dement: 2025


View all publications